Cite
HARVARD Citation
Fouts, T. et al. (n.d.). G-111 DNA prime/subunit boost using SIVE660 based rhFLSC yields 75% efficacy against cross clade SIVmac251 intrarectal challenge. Journal of acquired immune deficiency syndromes. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fouts, T. et al. (n.d.). G-111 DNA prime/subunit boost using SIVE660 based rhFLSC yields 75% efficacy against cross clade SIVmac251 intrarectal challenge. Journal of acquired immune deficiency syndromes. p. . [Online].